# | Title | Journal | Year | Citations |
---|
1 | Pustular Psoriasis: The Dawn of a New Era | Acta Dermato-Venereologica | 2020 | 56 |
2 | Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination | International Journal of Cancer | 2020 | 44 |
3 | Hematological immune related adverse events after treatment with immune checkpoint inhibitors | European Journal of Cancer | 2021 | 40 |
4 | Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis | Journal of Allergy and Clinical Immunology | 2022 | 35 |
5 | HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma | Blood | 2020 | 29 |
6 | Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection | Science Advances | 2021 | 27 |
7 | Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study | Rheumatology | 2021 | 17 |
8 | Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis | Frontiers in Oncology | 2021 | 10 |
9 | The Pathogenesis of Giant Condyloma Acuminatum (Buschke-Lowenstein Tumor): An Overview | International Journal of Molecular Sciences | 2022 | 10 |
10 | 1082MO 5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO+IPI) or NIVO alone | Annals of Oncology | 2020 | 8 |
11 | Sweet’s Syndrome Three Weeks after a Severe COVID-19 Infection: A Case Report | Acta Dermato-Venereologica | 2021 | 7 |
12 | 26591 Characterization of flares in patients with generalized pustular psoriasis—A population-based study from the French National Health Data System database (SNDS) | Journal of the American Academy of Dermatology | 2021 | 6 |
13 | Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature review | Annales De Dermatologie Et De Venereologie | 2022 | 6 |
14 | Emerging drugs for the treatment of basal cell carcinoma | Expert Opinion on Emerging Drugs | 2021 | 5 |
15 | Haemorrhagic shock secondary to a diffuse ulcerative enteritis after Ipilimumab and Nivolumab treatment for metastatic melanoma: a case report | Annals of Palliative Medicine | 2022 | 5 |
16 | Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme | JAMA Dermatology | 2021 | 5 |
17 | Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report | Acta Dermato-Venereologica | 2021 | 4 |
18 | Pustular Psoriasis and Associated Musculoskeletal Disorders | Journal of Rheumatology | 2021 | 3 |
19 | A Multicentre Randomised Controlled Study Evaluating the Effect of a Standardised Education Programme on Quality of Life, Disease Severity, and Disease Knowledge in Patients with Moderate-To-Severe Psoriasis: The EDUPSO Study | Dermatology | 2021 | 3 |
20 | Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological database | Immunotherapy | 2021 | 1 |
21 | Multicentric reticulohistiocytosis associated with organizing pneumonia | Joint Bone Spine | 2021 | 1 |
22 | Time to accurately determine the burden of generalized pustular psoriasis at the population level | British Journal of Dermatology | 2022 | 1 |
23 | Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma | Dermatologic Therapy | 0 | 1 |
24 | Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort | JCO Precision Oncology | 2022 | 1 |
25 | Reply to: Comment on “Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa” | Journal of the American Academy of Dermatology | 2021 | 0 |
26 | Case 41. Cutaneous Epstein–Barr Virus post-transplant lymphoproliferative disorder | | 2021 | 0 |
27 | A 3-Year-Old Child With Fever, Severe Cheilitis, and Blisters of the Palms and Soles | Clinical Infectious Diseases | 2021 | 0 |
28 | 26590 Design and rationale of Effisayil 1, a Phase II, multicenter, randomized, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis with an acute flare | Journal of the American Academy of Dermatology | 2021 | 0 |
29 | Treatment efficacy for Sézary syndrome: an international, multi-centre, comparative study of current systemic therapies | European Journal of Cancer | 2021 | 0 |
30 | Tumor Clone Frequency Calculation Using High-Throughput Sequencing of the TCRβ Gene in Patients with Folliculotropic Mycosis Fungoides | Journal of Investigative Dermatology | 2022 | 0 |
31 | POS1023 LONG-TERM SAFETY OF RISANKIZUMAB IN PATIENTS WITH PSORIATIC DISEASE: FINDINGS FROM INTEGRATED ANALYSES OF 17 CLINICAL TRIALS IN PSORIASIS AND 4 IN PSORIATIC ARTHRITIS | Annals of the Rheumatic Diseases | 2022 | 0 |
32 | Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients | Dermatology | 2023 | 0 |